Press Release
Friday, December 13, 2019
Signature of a Tripartite Agreement on the New Brunswick Centre for Precision Medicine
From left : Lynne Castonguay, Secretary General, Université de Moncton; Jacques Paul Couturier, Interim President and Vice-Chancellor, Université de Moncton; Dr. Rodney Ouellette, President and Scientific Director, ACRI; Gilles Lanteigne, President and CEO, Vitalité Health Network; and Gisèle Beaulieu, Vice-President of Performance, Quality and Corporate Services, Vitalité Health Network.
View Full-Size Image
On December 13 the Université de Moncton, the Vitalité Health Network and the Atlantic Cancer Research Institute (ACRI) signed a ten-year agreement establishing the governance model for the New Brunswick Centre for Precision Medicine (NBCPM).
Under this agreement each partner agrees to establish a governance model that will ensure fruitful consultation and ongoing constructive collaboration among the parties concerned to support research activities dealing with precision medicine in the region.
“The Centre for Precision Medicine is an innovative research project among the Université, the Vitalité Health Network and ACRI. With this agreement, the partners will be able to work together and make the Centre into a beacon of healthcare research in New Brunswick,” said Jacques Paul Couturier, interim President and Vice-Chancellor of the Université de Moncton. “For several years now the Université de Moncton has been intensifying its healthcare research activities and the Centre will allow us to increase them even more thanks to synergies with our partners.”
“This tripartite agreement adheres to our 2017-2020 Strategic Plan because it directly supports our mission as a university, in particular research, in a way that improves the quality and safety of care,” indicated Gilles Lanteigne, CEO of the Vitalité Health Network.
“In signing this agreement we are marking a turning point in health research in New Brunswick,” declared Dr. Rodney Ouellette, ACRI’s President and Scientific Director. “This collaborative agreement, and especially full deployment of the research teams at the NBCPM, will grow synergies and new opportunities. This avant-garde, patient-centered model will require a maximum contribution from experts in healthcare topics ranging from genomics to artificial intelligence in order to monitor disease in real time and provide targeted treatments. The NBCPM will count on an optimal infrastructure, a team of experts and innovative research in order to continue to make its mark nationally and internationally. This will generate even more spin-offs in healthcare, training and economic development for the region.”
The NBCPM is the first interdisciplinary health research centre in the province located in a clinical setting. The NBCPM brings together experts in fundamental and translational biomedical research, in clinical research, in genetic sequencing, in proteomic analysis and in public health. The goal of their research is to find possibilities and solutions that will transform patient care by administering the right treatments to the right patients at the right moment, as well as to provide a cutting-edge research and training environment for future healthcare professionals.
Return to Press release